STOCKHOLM, July 19, 2019 /PRNewswire/ -- Cyxone (publ), a Swedish biotech in autoimmune diseases, today announced that the company has signed an agreement with EGeen Inc., a clinical research organization (CRO), for conducting its upcoming clinical phase IIb trial with Rabeximod in rheumatoid arthritis (RA) in select Eastern European countries. Cyxone is now, together

VILNIUS, Lithuania, July 19, 2019 /PRNewswire/ -- Northway Biotechpharma, a leading biopharmaceutical contract development and manufacturing organization (CDMO), celebrates its 15th anniversary today. As a midsized CDMO, Northway Biotechpharma is able to provide flexibility and responsiveness backed by a strong foundation in science and technology. The company

THOUSAND OAKS, Calif., July 18, 2019 /PRNewswire/ -- Amgen (NASDAQ:AMGN) and Allergan plc (NYSE:AGN) today announced that MVASI™ (bevacizumab-awwb), a biosimilar to Avastin® (bevacizumab), and KANJINTITM (trastuzumab-anns), a biosimilar to Herceptin® (trastuzumab), are now available in the Unit

INCHEON, South Korea and HONG KONG, July 18, 2019 /PRNewswire/ -- Celltrion and Nan Fung Group announced today the establishment of Vcell Healthcare Limited, a Joint Venture company between both parties.At the formation of the Joint Venture, Vcell Healthcare Limited has simultaneously signed a licensing agreement with Celltrio

SAN FRANCISCO, July 18, 2019 /PRNewswire/ -- Leading plaintiffs' law firm Grant & Eisenhofer P.A. announced the filing of a sexual assault lawsuit against Massage Envy, the

SYRACUSE, N.Y., July 18, 2019 /PRNewswire/ -- FORTUNE magazine and Great Place to Work rank Bankers Healthcare Group, a

LOS ANGELES and BOSTON, July 18, 2019 /PRNewswire/ -- PHAR LLC (Los Angeles, CA and Boston, MA), a boutique health care consultancy dedicated to the practice of health economics and outcomes research, announces the appointment of Mallik Greene

SAN FRANCISCO, July 18, 2019 /PRNewswire/ -- Today, the San Francisco SPCA announced structural and strategic changes as part of Vision 2030 – an innovative plan to positively impact at least five million animals over the next ten years. Vision 2030 is a groundbreaking strategic plan that represents an important new chapter in the organization's 151-year histo

MECHANICSBURG, Pa., July 18, 2019 /PRNewswire/ -- As previously disclosed, Select Medical Holdings Corporation ("Select Medical") (NYSE: SEM) is currently in discussions with its lenders regarding a proposed refinancing of certain of its outstanding indebtedness. In connection with such discussions, Select Medical today announced an estimate of certain results for its se

FLINT, Mich., July 18, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its second-quarter 2019 operating results before market open Friday, August 9. A conference call and live webcast will be held at 8:30 a.m. ET.